Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ethylphenidate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ethylphenidate is a stimulant novel psychoactive substance that is an analogue of the prescription drug methylphenidate (Ritalin… Expand
Is this relevant?
2016
2016
The diffusion of New Psychoactive Substances (NPS) in the illicit drug market is a worldwide problem. The aim of the study is to… Expand
Is this relevant?
2015
2015
Ethylphenidate is a novel psychoactive substance with undocumented effects, risks, and motivation for use. In this study, we… Expand
Is this relevant?
2015
2015
To the Editor: Availability of novel psychoactive substances (NPS), or ‘legal highs’, has increased markedly over recent years… Expand
Is this relevant?
2014
2014
Methylphenidate, a psychostimulant drug from the group of amphetamines is, among others, established in the treatment of… Expand
Is this relevant?
2010
2010
In view of the widespread application of methylphenidate for attention-deficit/ hyperactivity disorder (ADHD) therapy its… Expand
Is this relevant?
2007
2007
Ethylphenidate is formed by metabolic transesterification of methylphenidate and ethanol. Study objectives were to (a) establish… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Ethanol elevates methylphenidate (1) plasma concentrations and yields the metabolite ethylphenidate (2). The therapeutic… Expand
Is this relevant?
2000
2000
Ethylphenidate was recently reported as a novel drug metabolite in two overdose fatalities where there was evidence of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
1999
1999
Methylphenidate is the most commonly prescribed psychostimulant in clinical use today. Known methylphenidate metabolites include… Expand
Is this relevant?